European Biotech Acquisition Corp (EBAC) Peer Comparison

$11.27

$-0.44 (-3.76%)

As on 02-Mar-2023 16:00EDT

Market cap

$184 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

559.5

P/B Ratio

1.3

Div. Yield

0 %

Edit

	European Biotech Acquisition Corp (EBAC)	Global Partner Acquisition II Corp (GPAC)
Market cap ($ Mln)	184	296
Revenue ($ Mln)	--	--
Net Profit ($ Mln)	0.34	-7.35
Net Margin (%)	11.57	--
RoE (%)	0.60	--
Price to Earnings	559.50	--
Price-To-Book	1.34	4.18

Cashflow
Ratios

Cashflow ($ Mln)

	European Biotech Acquisition Corp (EBAC)	Global Partner Acquisition II Corp (GPAC)
Cash From Operating Activities	-0.51	-1.53
Cash Flow from Investing Activities	--	--
Cash from Financing Activities	-0.05	0.79
Net Cash Inflow / Outflow	--	--

Ratios

Profitability Ratios

	European Biotech Acquisition Corp (EBAC)	Global Partner Acquisition II Corp (GPAC)
ROCE (%)	0.60	11.36
ROE (%)	0.60	11.37
ROA (%)	0.27	10.60
EBIT Margin (%)	--	--
Net Margin (%)	--	--
Cash Profit Margin (%)	--	--

Growth Ratios

	European Biotech Acquisition Corp (EBAC)	Global Partner Acquisition II Corp (GPAC)
Revenue Growth (%)	--	--
EBIT Growth (%)	--	--
Net Profit Growth (%)	-76.81	582.72
EPS Growth (%)	-0.70	5.83
Book Value Growth (%)	--	--

Valuation Ratios

	European Biotech Acquisition Corp (EBAC)	Global Partner Acquisition II Corp (GPAC)
Price / Earnings	375.69	11.80
Price / Book Value	1.06	1.31
Dividend Yield (%)	--	--
EV/EBITDA	374.79	-191.44
Market Cap ($ Cr)	--	--

Solvency Ratios

	European Biotech Acquisition Corp (EBAC)	Global Partner Acquisition II Corp (GPAC)
Debt to Equity	--	0.00
Short term debt to equity ratio	--	0.00
Current Ratio	0.45	0.03
Quick Ratio	--	--
Interest Coverage	--	-0.12

Operating Efficiency Ratios

	European Biotech Acquisition Corp (EBAC)	Global Partner Acquisition II Corp (GPAC)
Debtors to sales (%)	--	--
Asset Turnover	0.00	0.00
Receivable days	--	--
Inventory Days	--	--
Payable days	--	--
Cash Conversion Cycle	--	--

Annual
Quarterly